© 1996 Oxford University Press
other |
SHORT COMMUNICATION: Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis
Department of Nutritional Sciences, Faculty of Medicine, University of Toronto 150 College Street, Toronto,ON, M5S 3E2, Canada
1To whom correspondence should be addressed
Flaxseed, a rich source of mammalian lignan precursor secoisolariciresinol-diglycoside (S.D.) and 
-linolenic acid (ALA), has been shown to be protective at the early promotion stage of carcinogenesis. The objective of this study was to determine whether supplementation with flaxseed, its lignan or oil fractions, beginning 13 weeks after carcinogen administration, would reduce the size of established mammary tumors (present at the start of treatment) and appearance of new tumors in rats. Dietary groups consisted of the basal diet (BD, 20% corn oil) alone or supplemented with a gavage of2200 nmol/day S.D. [S.D., equal to level in 5% flaxseed (F)], 1.82% flaxseed oil (OIL, equal to levelin 5% F) or 2.5% or 5% flaxseed (2.5% F and 5% F, respectively). After 7 weeks of treatment, established tumor volume was over 50% smaller in all treatment groups (OIL, 2.5% F, 5% F, P< 0.04; S.D., P < 0.08) while there was no change in the BD group. New tumor number and volume were lowest in the S.D.(P < 0.02) and 2.5% F (P < 0.07) groups. The combined established and new tumor volumes were smaller for the S.D., 2.5% F and 5% F groups (P< 0.02) compared to the OIL and BD groups. The high negative correlation (r = –0.997, P < 0.001) between established tumor volume and urinary mammalian lignan excretion in the BD, S.D., 2.5% F and 5% F groups indicates that the reduction in tumor size is due in part to the lignans derived from the S.D. in flaxseed. However, there was no relationship between new or total tumor development and urinary lignan levels. The effect of flaxseed oil may be related to its high ALA content. In conclusion, the S.D. in flaxseed appears to be beneficial throughout the promotional phase of carcinogenesis whereas the oil component is more effective at the stage when tumors have already been established.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Chen, K. A. Power, J. Mann, A. Cheng, and L. U. Thompson Flaxseed Alone or in Combination with Tamoxifen Inhibits MCF-7 Breast Tumor Growth in Ovariectomized Athymic Mice with High Circulating Levels of Estrogen Experimental Biology and Medicine, September 1, 2007; 232(8): 1071 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. U. Thompson, J. M. Chen, T. Li, K. Strasser-Weippl, and P. E. Goss Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer Clin. Cancer Res., May 15, 2005; 11(10): 3828 - 3835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bylund, N. Saarinen, J.-X. Zhang, A. Bergh, A. Widmark, A. Johansson, E. Lundin, H. Adlercreutz, G. Hallmans, P. Stattin, et al. Anticancer Effects of a Plant Lignan 7-Hydroxymatairesinol on a Prostate Cancer Model In Vivo Experimental Biology and Medicine, March 1, 2005; 230(3): 217 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Qu, R. L. Madl, D. J. Takemoto, R. C. Baybutt, and W. Wang Lignans Are Involved in the Antitumor Activity of Wheat Bran in Colon Cancer SW480 Cells J. Nutr., March 1, 2005; 135(3): 598 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen, E. Hui, T. Ip, and L. U. Thompson Dietary Flaxseed Enhances the Inhibitory Effect of Tamoxifen on the Growth of Estrogen-Dependent Human Breast Cancer (MCF-7) in Nude Mice Clin. Cancer Res., November 15, 2004; 10(22): 7703 - 7711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. de Lemos and R. K. O'Brien Effects of flaxseed on breast cancer growth Journal of Oncology Pharmacy Practice, September 1, 2004; 10(3): 145 - 147. [Abstract] [PDF]
|
|
|
|
 |
|
 J. D Brooks, W. E Ward, J. E Lewis, J. Hilditch, L. Nickell, E. Wong, and L. U Thompson Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy Am. J. Clinical Nutrition, February 1, 2004; 79(2): 318 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Tan, J. Chen, W. E. Ward, and L. U. Thompson Mammary Gland Morphogenesis Is Enhanced by Exposure to Flaxseed or Its Major Lignan During Suckling in Rats Experimental Biology and Medicine, February 1, 2004; 229(2): 147 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen, K. P. Tan, W. E. Ward, and L. U. Thompson Exposure to Flaxseed or Its Purified Lignan during Suckling Inhibits Chemically Induced Rat Mammary Tumorigenesis Experimental Biology and Medicine, September 1, 2003; 228(8): 951 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tsuda, A. Naito, C. K. Kim, K. Fukamachi, H. Nomoto, and M. A. Moore Carcinogenesis and Its Modification by Environmental Endocrine Disruptors: In Vivo Experimental and Epidemiological Findings Jpn. J. Clin. Oncol., June 1, 2003; 33(6): 259 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Saarinen, R. Huovinen, A. Warri, S. I. Makela, L. Valentin-Blasini, R. Sjoholm, J. Ammala, R. Lehtila, C. Eckerman, Y. U. Collan, et al. Enterolactone Inhibits the Growth of 7,12-Dimethylbenz(a) anthracene-induced Mammary Carcinomas in the Rat Mol. Cancer Ther., August 1, 2002; 1(10): 869 - 876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kilkkinen, P. Pietinen, T. Klaukka, J. Virtamo, P. Korhonen, and H. Adlercreutz Use of Oral Antimicrobials Decreases Serum Enterolactone Concentration Am. J. Epidemiol., March 1, 2002; 155(5): 472 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pietinen, K. Stumpf, S. Männistö, V. Kataja, M. Uusitupa, and H. Adlercreutz Serum Enterolactone and Risk of Breast Cancer: A Case-Control Study in Eastern Finland Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 339 - 344. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Clemons and P. Goss Estrogen and the Risk of Breast Cancer N. Engl. J. Med., January 25, 2001; 344(4): 276 - 285. [Full Text] [PDF]
|
|
|
|
|
|
A. M. Hutchins, M. C. Martini, B. A. Olson, W. Thomas, and J. L. Slavin Flaxseed Influences Urinary Lignan Excretion in a Dose-dependent Manner in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1113 - 1118. [Abstract] [Full Text]
|
|
|
|
|
|
C. J. Haggans, E. J. Travelli, W. Thomas, M. C. Martini, and J. L. Slavin The Effect of Flaxseed and Wheat Bran Consumption on Urinary Estrogen Metabolites in Premenopausal Women Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 719 - 725. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. C.L. Tou and L. U. Thompson Exposure to flaxseed or its lignan component during different developmental stages influences rat mammary gland structures Carcinogenesis, September 1, 1999; 20(9): 1831 - 1835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Jenkins, C. W. Kendall, E. Vidgen, S. Agarwal, A V. Rao, R. S Rosenberg, E. P Diamandis, R. Novokmet, C. C Mehling, T. Perera, et al. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial Am. J. Clinical Nutrition, March 1, 1999; 69(3): 395 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D Nesbitt, Y. Lam, and L. U Thompson Human metabolism of mammalian lignan precursors in raw and processed flaxseed Am. J. Clinical Nutrition, March 1, 1999; 69(3): 549 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. L. Tou, J. Chen, and L. U. Thompson Flaxseed and Its Lignan Precursor, Secoisolariciresinol Diglycoside, Affect Pregnancy Outcome and Reproductive Development in Rats J. Nutr., November 1, 1998; 128(11): 1861 - 1868. [Abstract] [Full Text]
|
|
|
|
|
|
S. E. Rickard and L. U. Thompson Chronic Exposure to Secoisolariciresinol Diglycoside Alters Lignan Disposition in Rats J. Nutr., March 1, 1998; 128(3): 615 - 623. [Abstract] [Full Text]
|
|